Omnichannel Lead
Alexion
Omnichannel Lead
Alexion
Global biopharmaceuticals focusing on rare diseases
Job purpose
The Omnichannel Lead is a critical member of the Customer Experience & IT (CET) team, serving as a dedicated resource for Alexion Japan to drive fact-based, AI-enabled omnichannel engagement across the rare disease portfolio.
This role is responsible for translating patient journey insights, customer and consent data, sales data, real-world data, competitive intelligence, publications, and scientific activity into precise HCP segmentation and orchestrating engagement across owned, paid, MR, and D2D channels. The role will accelerate the integration of Alexion and AstraZeneca digital and customer engagement capabilities into AZKK’s One AZ Platform, enabling a unified omnichannel engagement ecosystem powered by AI-driven personalization, next best action recommendations, and marketing automation. The role will support the business-led design, deployment, and adoption of Salesforce Life Sciences Cloud and associated CRM, customer data, marketing automation, and decisioning capabilities
The Omnichannel Lead will work closely with stakeholders across Marketing, Sales, Medical, Patient Centricity, Analytics, IT, APJ market and external partners to lead strategy development, requirement definition, implementation, change management, adoption, and value tracking. This role is expected to balance standardization with local business needs while delivering measurable improvements in patient and HCP engagement, conversion, campaign effectiveness, and commercial productivity.
Role and Responsibilities
Strategic Partnership & Planning
Program Leadership & Execution
Capability Enablement & Adoption
Insight Integration & Value Demonstration
Vendor & Technology Enablement
Education, Qualifications and Experiences
Education
Experience
Skills & Competencies
Technical Skills
Preferred Skills and Capabilities
Language
Key Relationships to reach solutions
Date Posted
26-10月-2026Closing Date
30-12月-2026Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact [email protected]. Alexion participates in E-Verify.
Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.
Explore more opportunities at Alexion